$115 Million is the total value of Virtus ETF Advisers LLC's 246 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SQM | New | SOCIEDAD QUIMICA MINERA DE Cspon adr ser b | $103,000 | – | 2,101 | +100.0% | 0.09% | – |
| IBM | New | INTERNATIONAL BUSINESS MACHS | $29,000 | – | 186 | +100.0% | 0.02% | – |
| HAL | New | HALLIBURTON CO | $27,000 | – | 585 | +100.0% | 0.02% | – |
| ROP | New | ROPER TECHNOLOGIES INC | $27,000 | – | 95 | +100.0% | 0.02% | – |
| EOG | New | EOG RES INC | $24,000 | – | 225 | +100.0% | 0.02% | – |
| TEL | New | TE CONNECTIVITY LTD | $21,000 | – | 210 | +100.0% | 0.02% | – |
| MRO | New | MARATHON OIL CORP | $21,000 | – | 1,330 | +100.0% | 0.02% | – |
| DG | New | DOLLAR GEN CORP NEW | $21,000 | – | 220 | +100.0% | 0.02% | – |
| A | New | AGILENT TECHNOLOGIES INC | $21,000 | – | 320 | +100.0% | 0.02% | – |
| HUM | New | HUMANA INC | $20,000 | – | 73 | +100.0% | 0.02% | – |
| MPC | New | MARATHON PETE CORP | $19,000 | – | 265 | +100.0% | 0.02% | – |
| PXD | New | PIONEER NAT RES CO | $18,000 | – | 105 | +100.0% | 0.02% | – |
| INFO | New | IHS MARKIT LTD | $19,000 | – | 385 | +100.0% | 0.02% | – |
| ZBH | New | ZIMMER BIOMET HLDGS INC | $17,000 | – | 155 | +100.0% | 0.02% | – |
| KLAC | New | KLA-TENCOR CORP | $16,000 | – | 149 | +100.0% | 0.01% | – |
| FLT | New | FLEETCOR TECHNOLOGIES INC | $16,000 | – | 80 | +100.0% | 0.01% | – |
| STX | New | SEAGATE TECHNOLOGY PLC | $15,000 | – | 250 | +100.0% | 0.01% | – |
| FFIV | New | F5 NETWORKS INC | $14,000 | – | 98 | +100.0% | 0.01% | – |
| DISCK | New | DISCOVERY COMMUNICATNS NEW | $13,000 | – | 676 | +100.0% | 0.01% | – |
| LYB | New | LYONDELLBASELL INDUSTRIES N | $13,000 | – | 119 | +100.0% | 0.01% | – |
| OXY | New | OCCIDENTAL PETE CORP DEL | $11,000 | – | 170 | +100.0% | 0.01% | – |
| FCX | New | FREEPORT-MCMORAN INCcl b | $12,000 | – | 694 | +100.0% | 0.01% | – |
| CSX | New | CSX CORP | $11,000 | – | 205 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC | 31 | Q3 2023 | 1.7% |
| REGENERON PHARMACEUTICALS | 31 | Q3 2023 | 1.8% |
| INCYTE CORP | 31 | Q3 2023 | 2.1% |
| ENANTA PHARMACEUTICALS INC | 31 | Q3 2023 | 2.2% |
| EXELIXIS INC | 31 | Q3 2023 | 1.8% |
| VANDA PHARMACEUTICALS INC | 31 | Q3 2023 | 1.7% |
| IRONWOOD PHARMACEUTICALS INC | 31 | Q3 2023 | 2.0% |
| LIGAND PHARMACEUTICALS INC | 31 | Q3 2023 | 1.5% |
| GILEAD SCIENCES INC | 31 | Q3 2023 | 1.6% |
| HALOZYME THERAPEUTICS INC | 31 | Q3 2023 | 1.7% |
View Virtus ETF Advisers LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-15 |
| 13F-HR | 2023-11-07 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Virtus ETF Advisers LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.